Showing results (231-240 of 272) with videos related to

Sort By:
Pageof 28
Trials|June 18, 2020
The adaptive designs CONSORT extension (ACE) statement: a checklist with explanation and elaboration guideline for reporting randomised trials that use an adaptive designMunyaradzi Dimairo, Philip Pallmann, James Wason, et al.
Trials|September 19, 2014
The INTERVAL trial to determine whether intervals between blood donations can be safely and acceptably decreased to optimise blood supply: study protocol for a randomised controlled trialCarmel Moore, Jennifer Sambrook, Matthew Walker, et al.
BMJ (Clinical Research Ed.)|January 15, 2014
Endovascular or open repair strategy for ruptured abdominal aortic aneurysm: 30 day outcomes from IMPROVE randomised trial, Janet T Powell, Michael J Sweeting, et al.
BMC Medicine|October 2, 2025
Practical guidance for conducting high-quality and rapid interim analyses in adaptive clinical trialsHelen Mossop, Zoë Walmsley, Nina Wilson, et al.
BMC Medicine|October 26, 2021
Costs and staffing resource requirements for adaptive clinical trials: quantitative and qualitative results from the Costing Adaptive Trials projectNina Wilson, Katie Biggs, Sarah Bowden, et al.
JAMA|November 12, 2009
Major lipids, apolipoproteins, and risk of vascular disease, Emanuele Di Angelantonio, Nadeem Sarwar, et al.
The Lancet. Rheumatology|May 24, 2025
Treatment outcomes in patients with VEXAS syndrome: a retrospective cohort studyAdam Al-Hakim, Roochi Trikha, Ei Ei Phyu Htut, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|December 19, 2003
Variation in the urokinase-plasminogen activator gene does not explain the chromosome 10 linkage signal for late onset ADAmanda J Myers, Helen Marshall, Peter Holmans, et al.
Plos One|February 10, 2012
Routine antenatal anti-D prophylaxis in women who are Rh(D) negative: meta-analyses adjusted for differences in study design and qualityRebecca M Turner, Myfanwy Lloyd-Jones, Dilly O C Anumba, et al.
Lancet (London, England)|May 4, 2010
Lipoprotein-associated phospholipase A(2) and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies, Alexander Thompson, Pei Gao, et al.
Pageof 28